Welcome to our dedicated page for Bioharvest news (Ticker: CNVCF), a resource for investors and traders seeking the latest updates and insights on Bioharvest stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bioharvest's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bioharvest's position in the market.
BioHarvest Sciences Inc. has successfully increased Cannabis cell production with trichomes by 250x, transitioning to medium-scale bioreactors. This milestone is crucial for advancing to industrial-scale production and aims for commercialization of Cannabis and Hemp products in H1 2022. The proprietary Amalgamated Trichomes Coral Structure technology is key to this scale-up, ensuring resilience during growth. The Company’s CEO expressed confidence that this development will lead to a significant shift in Cannabis adoption in food and health sectors.
Summary not available.